Psychedelics Then and Now with Zach Leary - Episode 41 - Aubrey Marcus

Episode 41 - Aubrey Marcus

05/01/21 • 58 min

Psychedelics Then and Now with Zach Leary

The MAPS Podcast returns with a new episode featuring Aubrey Marcus, the founder and CEO of ONNIT.

Aubrey Marcus is the founder of Onnit, a lifestyle brand based on a holistic health philosophy he calls Total Human Optimization. Since its founding, Onnit has become an Inc. 500 company and industry leader with over 250 products ranging from peak performance supplements to foods, fitness equipment, and apparel.

Aubrey discusses the effects psychedelics have on our mystical state of awareness as well as our physical holistic selves. He is candid and visionary in his approach to how psychedelics have informed all aspects of his life and our culture at large.

The Multidisciplinary Association for Psychedelic Studies (MAPS) Podcast is hosted by Zach Leary and aims to bring you discussions with some of the leaders in the new age of psychedelic research and culture.

The MAPS Podcast returns with a new episode featuring Aubrey Marcus, the founder and CEO of ONNIT.

Previous Episode

Episode 40 - David Jay Brown, A Legend in Psychedelic Consciousness

This episode of the MAPS podcast features a dynamic consciousness surfing conversation with author David Jay Brown. I've known David for over 30 years and have watched him dance with the legends of psychedelic culture, exchange ideas with them and then morph into a legend all his own. From John Lilly to Albert Hoffman to Tim Leary, David always managed to extract the best from these brilliant minds and then build off of it to form his own magnificent insights into alternative culture and trans-personal evolution. Our conversation ranged from revisiting history to today's psychedelic research and its mind expanding potentials.

David Jay Brown is an American writer, interviewer and consciousness researcher. Brown has studied parapsychology, and the effects of psychoactive drugs. With parapsychologist Rupert Sheldrake, he studied pets and people who apparently anticipate events. Brown has served as a guest editor for the Multidisciplinary Association for Psychedelic Studies (MAPS), and he has published many interviews of prominent thinkers.

Next Episode

Episode 42 - Dr. Robin Carhart-Harris

This all new episode of the MAPS Podcast features an interview with Dr. Robin Carhart-Harris, a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London.

Dr. Carhart-Harris takes us through the near exhaustive psychedelic research that he's personally overseen as well as sharing his thoughts on the future of psychedelics and their influence on science, therapy and our culture at large.

Robin Carhart-Harris is a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. He coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.

After being awarded an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, he relocated to Imperial College London to continue his fMRI research with the classic psychedelic psilocybin. In conjunction with David Nutt, he built up a program of psychedelic research that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA, and plans for an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.